Article info
PDFCase study
Long-term response to olaparib in BRCA1-related ovarian cancer with brain metastases
- Correspondence to Dr Alejandro Gallego, Department of Medical Oncology, Hospital Universitario La Paz, Madrid CP 28046, Spain; alex_gallego{at}hotmail.es
Citation
Long-term response to olaparib in BRCA1-related ovarian cancer with brain metastases
Publication history
- Accepted January 27, 2021
- First published September 6, 2021.
Online issue publication
February 26, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.